Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Pharmacokinetics of amitriptyline in the elderly

Henry, J.F.; Altamura, C.; Gomeni, R.; Hervy, M.P.; Forette, F.; Morselli, P.L.

International Journal of Clinical Pharmacology Therapy and Toxicology 19(1): 1-5

1981

ISSN/ISBN: 0174-4879
PMID: 7203728
Document Number: 5606
The pharmacokinetics of amitryptyline (AMI) have been evaluated in six healthy elderly volunteers (72-83 years of age) after a single dose of 125 mg of AMI-HCl. AMI was absorbed rather slowly (mean peak time 10.4 +/- 1.6 hrs) but very efficiently (F: 0.59-0.75). The rate of formation of nortriptyline (NT) as well as the appearance clearance values (0.18-0.45 l/h/kg) of AMI were significantly lower than those previously described for younger subjects. Reversible alterating ECG were observed in 5 cases concomitantly with AMI peak plasma concentrations. The results indicate the desirability of reduced and/or divided daily doses of AMI in the elderly.

Document emailed within 1 workday
Secure & encrypted payments

Pharmacokinetics of amitriptyline in the elderly

Montgomery, S.A.; Mcauley, R.; Montgomery, D.B.; Dawling, S.; Braithwaite, R.A. 1980: Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial Clinical Therapeutics 3(4): 292-310
Degen, J.; Wölke, E.; Seiberling, M.; Pintar, P.; Höxter, G.; Steinhauer, H.B.; Fischer, W. 1993: Comparative study of the pharmacokinetics of amitriptyline oxide and trimipramine after single administration in healthy male probands and patients with renal failure Medizinische Klinik 88(3): 129-133; 171
Houck, J. 1970: Combined therapy in anxiety-depressive syndromes. II. Comparative effects of amitriptyline and limbitrol (chlordiazepoxide-amitriptyline) Diseases of the Nervous System 31(6): 421-426
Casacchia, M.; Cerbo, R.; Corona, R.; Boni, B. 1981: Double-blind study of the effects of amitriptyline and of a combination of amitriptyline and lithium on patients with chronic primary headache Rivista di Neurologia 51(2): 114-123
Pfaffenrath, V.; Diener, H.C.; Isler, H.; Meyer, C.; Scholz, E.; Taneri, Z.; Wessely, P.; Zaiser-Kaschel, H.; Haase, W.; Fischer, W. 1993: Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo Der Nervenarzt 64(2): 114-120
Pinheiro, R.L. 1992: Pharmacokinetics in the elderly Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(2): 191-197
Hougaard, C.; Matthiesen, T.B.; Rittig, S.; Djurhuus, J.C. 1997: Bioavailability and pharmacokinetics of desmopressin in elderly men Scandinavian Journal of Urology and Nephrology. Supplementum 183: 53-54
Fraser, G.L.; D'Amato, S. 1993: Vancomycin pharmacokinetics in elderly patients Clinical Pharmacy 12(7): 481
Leonard, A.E.; Boro, M.S. 1994: Vancomycin pharmacokinetics in middle-aged and elderly men American Journal of Hospital Pharmacy 51(6): 798-800
Kobayashi, K.A.; Bauer, L.A.; Horn, J.R.; Opheim, K.; Wood, F.; Kradjan, W.A. 1988: Glipizide pharmacokinetics in young and elderly volunteers Clinical Pharmacy 7(3): 224-228
Moreau, X.; Le Quay, L.; Granry, J.C.; Boishardy, N.; Delhumeau, A. 1993: Pharmacokinetics of paracetamol in the cerebrospinal fluid in the elderly Therapie 48(4): 393-396
Baumann, P. 1998: Care of depression in the elderly: comparative pharmacokinetics of SSRIs International Clinical Psychopharmacology 13(Suppl): S35-S43
Poggesi, I.; Pellizzoni, C.; Fleishaker, J.C. 2000: Pharmacokinetics of reboxetine in elderly patients with depressive disorders International Journal of Clinical Pharmacology and Therapeutics 38(5): 254-259
Guay, D.R.; Awni, W.M.; Peterson, P.K.; Obaid, S.; Breitenbucher, R.; Matzke, G.R. 1987: Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients American Journal of Medicine 82(4a): 124-129
Veyssier, P.; Darchis, J.P.; Devillers, A. 1988: Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly Therapie 43(Suppl 4): 355-359
Lefebvre, R.A.; Rosseel, M.T.; Bernheim, J. 1988: Single dose pharmacokinetics of cetirizine in young and elderly volunteers International Journal of Clinical Pharmacology Research 8(6): 463-470
Guay, D.R.; Awni, W.M.; Peterson, P.K.; Obaid, S.; Stein, D.; Breitenbucher, R.; Matzke, G.R. 1988: Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients International Journal of Clinical Pharmacology Therapy and Toxicology 26(6): 279-284
Kumagai, Y.; Yokota, S.; Isawa, S.; Murasaki, M.; Mukai, H.; Miyatake, S. 1999: Comparison of pharmacokinetics of NS-105, a novel agent for cerebrovascular disease, in elderly and young subjects International Journal of Clinical Pharmacology Research 19(1): 1-8
Peter, G.; Romeis, P.; Borbe, H.O.; Büker, K.M.; Riethmüller-Winzen, H. 1995: Tolerability and pharmacokinetics of single and multiple doses of azelastine hydrochloride in elderly volunteers Arzneimittel-Forschung 45(5): 576-581
Mück, W.; Heine, P.R.; Schmage, N.; Niklaus, H.; Horkulak, J.; Breuel, H.P. 1995: Steady-state pharmacokinetics of nimodipine during chronic administration of indometacin in elderly healthy volunteers Arzneimittel-Forschung 45(4): 460-462